Financhill
Back

Processa Pharmaceuticals, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
15

PCSA
Processa Pharmaceuticals, Inc.

Last Price:
$3.49
Seasonality Move:
51.74%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PCSA is experiencing slight selling pressure.

Processa Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 4.35 Sell
20-day SMA: 5.78 Sell
50-day SMA: 7.14 Sell
200-day SMA: 6.7 Sell
8-day EMA: 4.41 Sell
20-day EMA: 5.48 Sell
50-day EMA: 6.35 Sell
200-day EMA: 11.71 Sell

Processa Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.93 Sell
Relative Strength Index (14 RSI): 38.81 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.58 - 7.42) Sell
Bollinger Bands (100): (4.63 - 8.21) Sell

Processa Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Processa Pharmaceuticals, Inc. Stock

Is Processa Pharmaceuticals, Inc. Stock a Buy?

PCSA Technical Analysis vs Fundamental Analysis

Sell
15
Processa Pharmaceuticals, Inc. (PCSA) is a Sell

Is Processa Pharmaceuticals, Inc. a Buy or a Sell?

Processa Pharmaceuticals, Inc. Stock Info

Market Cap:
8M
Price in USD:
3.51
Share Volume:
133.1K

Processa Pharmaceuticals, Inc. 52-Week Range

52-Week High:
27.00
52-Week Low:
2.74
Sell
15
Processa Pharmaceuticals, Inc. (PCSA) is a Sell

Processa Pharmaceuticals, Inc. Share Price Forecast

Is Processa Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Processa Pharmaceuticals, Inc.

Is Processa Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $1.95 per share, a decrease next quarter of $0.00 per share, an increase this year of $90.50 per share, and an increase next year of $7.00 per share.

Technical Analysis of Processa Pharmaceuticals, Inc.

Should I short Processa Pharmaceuticals, Inc. stock?

* Processa Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.